ATFA
TEVA icon

All Terrain Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

All Terrain Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20,000
Closed -$180K – 109
2020
Q3 		$180K Hold
20,000
– – 0.06% 81
2020
Q2 		$247K Hold
20,000
– – 0.1% 79
2020
Q1 		$180K Buy
+20,000
New +$205K 0.07% 133

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

All Terrain Financial Advisors's TEVA Position: Q4 2020 in Review

All Terrain Financial Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2020, closing a stake of 20,000 shares — an estimated $180K sold.

All Terrain Financial Advisors first reported a position in TEVA in Q1 2020 and held it in 3 quarters. The position peaked at $247K in Q2 2020. 449 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • All Terrain Financial Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • All Terrain Financial Advisors sold 20,000 Teva Pharmaceuticals shares in Q4 2020, an estimated $180K.
  • All Terrain Financial Advisors first reported a position in Teva Pharmaceuticals in Q1 2020 and held it in 3 quarters.
  • All Terrain Financial Advisors's Teva Pharmaceuticals position peaked at $247K in Q2 2020.
  • 449 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2020.

Based on All Terrain Financial Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.